Author Correction: Reverse engineering synthetic antiviral amyloids

Nat Commun. 2023 Jun 13;14(1):3492. doi: 10.1038/s41467-023-39293-9.

Emiel Michiels^#^{1

2}, Kenny Roose^#^{3

4}, Rodrigo Gallardo^{1

2}, Ladan Khodaparast^{1

2}, Laleh Khodaparast^{1

2}, Rob van der Kant^{1

2}, Maxime Siemons^{1

2

5}, Bert Houben^{1

2}, Meine Ramakers^{1

2}, Hannah Wilkinson^{1

2}, Patricia Guerreiro^{1

2}, Nikolaos Louros^{1

2}, Suzanne J F Kaptein⁶, Lorena Itatí Ibañez^{3

4}, Anouk Smet^{3

4}, Pieter Baatsen^{1

7}, Shu Liu⁸, Ina Vorberg^{8

9}, Guy Bormans⁵, Johan Neyts⁶, Xavier Saelens^{3

4}, Frederic Rousseau^{10

11}, Joost Schymkowitz^{12

13}

¹ VIB Center for Brain and Disease Research, Leuven, Belgium.
² Switch Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
³ VIB Center for Medical Biotechnology, Ghent, Belgium.
⁴ Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
⁵ Laboratory for Radiopharmacy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
⁶ Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
⁷ Electron Microscopy Platform of VIB Bio Imaging Core, KU Leuven, Leuven, Belgium.
⁸ German Center for Neurodegenerative Diseases (DZNE e.V.), Bonn, Germany.
⁹ Rheinische Friedrich-Wilhelms-Universität Bonn, Bonn, Germany.
¹⁰ VIB Center for Brain and Disease Research, Leuven, Belgium. frederic.rousseau@kuleuven.vib.be.
¹¹ Switch Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium. frederic.rousseau@kuleuven.vib.be.
¹² VIB Center for Brain and Disease Research, Leuven, Belgium. joost.schymkowitz@kuleuven.vib.be.
¹³ Switch Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium. joost.schymkowitz@kuleuven.vib.be.

^# Contributed equally.

No abstract available

Publication types